- Home
- NVFY vs IMNN Comparison
NVFY vs IMNN Comparison
Compare NVFY & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- IMNN
- Stock Information
- Founded
- NVFY 2003
- IMNN 1982
- Country
- NVFY United States
- IMNN United States
- Employees
- NVFY N/A
- IMNN N/A
- Industry
- NVFY Home Furnishings
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- IMNN Health Care
- Exchange
- NVFY Nasdaq
- IMNN Nasdaq
- Market Cap
- NVFY 14.3M
- IMNN 12.1M
- IPO Year
- NVFY N/A
- IMNN 1985
- Fundamental
- Price
- NVFY $1.22
- IMNN $1.46
- Analyst Decision
- NVFY
- IMNN Buy
- Analyst Count
- NVFY 0
- IMNN 2
- Target Price
- NVFY N/A
- IMNN $14.00
- AVG Volume (30 Days)
- NVFY 36.5K
- IMNN 31.6M
- Earning Date
- NVFY 05-15-2025
- IMNN 05-12-2025
- Dividend Yield
- NVFY N/A
- IMNN N/A
- EPS Growth
- NVFY N/A
- IMNN N/A
- EPS
- NVFY N/A
- IMNN N/A
- Revenue
- NVFY $9,946,300.00
- IMNN N/A
- Revenue This Year
- NVFY N/A
- IMNN N/A
- Revenue Next Year
- NVFY N/A
- IMNN N/A
- P/E Ratio
- NVFY N/A
- IMNN N/A
- Revenue Growth
- NVFY N/A
- IMNN N/A
- 52 Week Low
- NVFY $0.39
- IMNN $0.37
- 52 Week High
- NVFY $2.08
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- NVFY 55.19
- IMNN 52.73
- Support Level
- NVFY $0.91
- IMNN $0.85
- Resistance Level
- NVFY $1.22
- IMNN $3.16
- Average True Range (ATR)
- NVFY 0.19
- IMNN 0.52
- MACD
- NVFY -0.03
- IMNN 0.03
- Stochastic Oscillator
- NVFY 40.79
- IMNN 39.07
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).